A medical device company spun out of the University of Glasgow has secured £4.7 million in its bid to accelerate ‘next generation respiratory pharmaceuticals’.
Nebu Flow is a Scotland-based biopharmaceutical company that researches and develops inhaled drugs for the treatment of patients with respiratory disorders.